Center for Structural Heart Disease, Structural Heart Disease Fellowship Director, Director of Research for the Center for Structural Heart Disease, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI, 48202, USA.
Emory University, Atlanta, GA, USA.
Curr Cardiol Rep. 2019 Oct 31;21(11):134. doi: 10.1007/s11886-019-1220-y.
Examine the latest data and techniques regarding transcaval access and closure.
Transcaval access was proven to be a feasible and a translatable skill in a 100 patient open-label prospective study. No late complications from fistulas occurred and of all patients alive at 1 year, one fistula remained open. Transcaval is a viable access route for large bore devices. With adequate planning, bleeding and vascular complications are minimal. It should be integrated into the rubric of transcatheter large bore access.
研究关于经腔静脉入路和封堵的最新数据和技术。
在一项 100 例开放标签前瞻性研究中，经腔静脉入路被证明是一种可行且可转化的技术。没有瘘管发生迟发性并发症，所有在 1 年内存活的患者中，有 1 例瘘管仍然开放。经腔静脉是大口径器械的可行入路。只要进行充分的规划，出血和血管并发症的风险就很小。它应该被纳入经导管大口径入路的范畴。
